Literature DB >> 2881152

Symptomatic hypocalcaemia after treatment with high-dose aminohydroxypropylidene diphosphonate.

D I Jodrell, T J Iveson, I E Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2881152     DOI： 10.1016/s0140-6736(87)90255-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Severe hypocalcaemia [corrected] after treatment with diphosphonate and aminoglycoside.

Authors:  U Pedersen-Bjergaard; J Myhre
Journal:  BMJ       Date:  1991-02-02

2.  Electrocardiographic Q-Tc prolongation associated with infusion of intravenous pamidronate disodium.

Authors:  N Varma; G N Kerrigan
Journal:  Postgrad Med J       Date:  1993-06       Impact factor: 2.401

3.  Prolonged, symptomatic hypocalcemia with pamidronate administration and subclinical hypoparathyroidism.

Authors:  A Mishra; L Wong; J Jonklaas
Journal:  Endocrine       Date:  2001-03       Impact factor: 3.633

Review 4.  Safety of long-term bisphosphonate therapy for the management of osteoporosis.

Authors:  E Michael Lewiecki
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

Review 5.  Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.

Authors:  A Fitton; D McTavish
Journal:  Drugs       Date:  1991-02       Impact factor: 9.546

Review 6.  Current recommendations for laboratory testing and use of bone turnover markers in management of osteoporosis.

Authors:  Jehoon Lee; Samuel Vasikaran
Journal:  Ann Lab Med       Date:  2012-02-23       Impact factor: 3.464

7.  Bisphosphonate-induced Severe Hypocalcemia - A Case Report -.

Authors:  Won-Seok Do; Jin-Kyung Park; Myung-Il Park; Hyeong-Seok Kim; Sung-Ho Kim; Duk-Hyun Lee
Journal:  J Bone Metab       Date:  2012-11-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.